Zydus Gets FCA Claims Trimmed In Generics Pricing Row
A New Jersey federal judge on Tuesday narrowed a whistleblower suit accusing Zydus Pharmaceutical USA Inc. of violating several False Claims Acts by inflating the price of its generic drugs, finding...To view the full article, register now.
Already a subscriber? Click here to view full article